LUMOS PHARMA, INC. (LUMO) Net Income (Loss) Attributable to Parent USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Lumos Pharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2024.
  • Lumos Pharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$10.4 M, a 42.1% decline year-over-year.
  • Lumos Pharma, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$37.1 M, a 21% decline year-over-year.
  • Lumos Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$34 M, a 9.57% decline from 2022.
  • Lumos Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$31.1 M, a 2.08% decline from 2021.
  • Lumos Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$30.4 M, a 437% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$37.1 M -$10.4 M -$3.1 M -42.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$34 M -$9.46 M -$1.21 M -14.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 -$32.8 M -$8.3 M -$1.05 M -14.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$31.8 M -$8.93 M -$1.09 M -13.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-07
Q1 2023 -$30.7 M -$7.35 M +$374 K +4.85% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$31.1 M -$8.25 M -$2.61 M -46.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 -$28.5 M -$7.25 M +$237 K +3.17% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$28.7 M -$7.84 M +$826 K +9.53% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-07
Q1 2022 -$29.5 M -$7.72 M +$911 K +10.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-07
Q4 2021 -$30.4 M -$5.64 M -$3.23 M -134% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-07
Q3 2021 -$27.2 M -$7.49 M -$9.25 M -524% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$18 M -$8.67 M -$3.32 M -62% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$14.6 M -$8.63 M -$8.97 M -2639% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$5.66 M -$2.42 M +$5.86 M +70.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 -$11.5 M $1.77 M +$4.43 M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$16 M -$5.35 M -$2.78 M -108% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-05
Q1 2020 -$13.2 M $340 K +$2.45 M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-05
Q4 2019 -$15.6 M -$8.27 M +$2.3 M +21.7% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-03
Q3 2019 -$17.9 M -$2.67 M +$4.73 M +63.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$22.6 M -$2.57 M +$14.7 M +85.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-12
Q1 2019 -$37.4 M -$2.11 M +$16.2 M +88.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-12
Q4 2018 -$53.6 M -$10.6 M +$3.12 M +22.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-03
Q3 2018 -$56.7 M -$7.4 M +$13.2 M +64.1% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-03
Q2 2018 -$69.9 M -$17.3 M -$587 K -3.51% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-03
Q1 2018 -$69.3 M -$18.3 M +$2.6 M +12.4% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-03
Q4 2017 -$72 M -$13.7 M -$180 K -1.33% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-05
Q3 2017 -$71.8 M -$20.6 M -$5.09 M -32.7% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-05
Q2 2017 -$66.7 M -$16.7 M +$15.7 M +48.4% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-05
Q1 2017 -$82.3 M -$20.9 M +$2.81 M +11.8% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-05
Q4 2016 -$85.2 M -$13.5 M +$8.07 M +37.4% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-05
Q3 2016 -$93.2 M -$15.5 M +$366 K +2.3% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-05
Q2 2016 -$93.6 M -$32.4 M -$18.3 M -130% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-05
Q1 2016 -$75.3 M -$23.7 M -$34.9 M -312% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-05
Q4 2015 -$40.4 M -$21.6 M -$142 M -118% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-06
Q3 2015 $101 M -$15.9 M -$10.3 M -184% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-06
Q2 2015 $112 M -$14.1 M -$4.93 M -53.8% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-06
Q1 2015 $116 M $11.2 M +$20.4 M Jan 1, 2015 Mar 31, 2015 10-K 2017-03-06
Q4 2014 $96 M $120 M +$128 M Oct 1, 2014 Dec 31, 2014 10-K 2016-02-29
Q3 2014 -$32 M -$5.6 M +$2.53 M +31.1% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-29
Q2 2014 -$34.6 M -$9.16 M -$2.09 M -29.5% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-29
Q1 2014 -$32.5 M -$9.24 M -$1.3 M -16.4% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-29
Q4 2013 -$31.2 M -$8.05 M -$1.73 M -27.3% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-16
Q3 2013 -$29.5 M -$8.12 M -$2.27 M -38.8% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-16
Q2 2013 -$27.2 M -$7.08 M -$768 K -12.2% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-16
Q1 2013 -$26.4 M -$7.93 M -$3.09 M -63.9% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-16
Q4 2012 -$23.3 M -$6.32 M -$509 K -8.76% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-16
Q3 2012 -$22.8 M -$5.85 M -$1.87 M -46.8% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 -$20.9 M -$6.31 M -$1.92 M -43.6% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 -$19 M -$4.84 M -$945 K -24.2% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 -$18.1 M -$5.81 M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-12
Q3 2011 -$3.99 M +$1.05 M +20.8% Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-31
Q2 2011 -$4.39 M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$3.9 M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q3 2010 -$5.03 M Jul 1, 2010 Sep 30, 2010 10-Q/A 2012-01-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.